Analysis of Anti-infective Treatment and Monitoring of Adverse Reactions in a Case of Pulmonary Infection with Multidrug Resistant Acinetobacter Baumannii
Abstract
Keywords
References
Infectious group, respiratory branch, Chinese Medical Association.
Guidelines for the diagnosis and treatment of hospital acquired
pneumonia and ventilator-associated pneumonia in Chinese adult
hospitals (2018 Edition)[J]. Chinese Journal of tuberculosis and
respiration, 2018, 41 (4): 255-280.
World Health Organization. “Guidelines for the Prevention and
Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter
baumannii and Pseudomonas aeruginosa in Health Care
Facilities.” (2017).
Peleg A Y, Seifert H, Paterson D L. Acinetobacter baumannii:
emergence of a successful pathogen.[J]. Clinical Microbiology Reviews,
, 21(3):538-582.
Nikolich-Ugich J. The twilight of immunity: emerging concepts
in aging of the immune system[J]. Nature Immunology, 2017,
(1):10-19.
Henig O, Kaye K S. Bacterial Pneumonia in Older Adults[J]. Infect
Dis Clin North Am, 2017:págs. 689-713.
Benson, and M. John. “Antimicrobial Pharmacokinetics and Pharmacodynamics
in Older Adults.” Infectious Disease Clinics of
North America 31.4(2017):609.
Chen Baiyi, he Lixian, Hu Bijie, et al. Consensus of Chinese ex-perts on diagnosis, treatment and prevention of Acinetobacter baumannii
infection[J]. Chinese medical science, 2012.
Shaw AC, Goldstein DR, Montgomery RR. Age-dependent dysregulation
of innate immunity. Nat Rev Immunol.2013;13:875-887.
Chakhtoura N E, Bonomo R A, Jump R . Influence of Aging and
Environment on Presentation of Infection in Older Adults[J]. Infectious
Disease Clinics of North America, 2017, 31(4):593-608.
Song Ge. Application of bronchoalveolar lavage in the treatment
of respiratory critical illness[C] /academic conference of
critical illness medical professional committee of Shandong
pathophysiology society. Critical illness medical professional
committee of Shandong pathophysiology society; Emergency
medical doctors branch of Shandong Medical Association, 2013.
Patel, I S. Relationship between bacterial colonisation and the
frequency, character, and severity of COPD exacerbations[J].
Thorax, 2002, 57(9):759.
Respiratory branch of Chinese Medical Association. Guidelines
for the diagnosis and treatment of community-acquired pneumonia
in Chinese adults (2016 Edition)[J]. Chinese Journal of tuberculosis
and respiration, 2016,39 (4): 253-279.
Higgins P G, Wisplinghoff H, Krut O, et al. A PCR-based method
to differentiate between Acinetobacter baumannii and Acinetobacter
genomic species 13TU[J]. Clinical Microbiology and
Infection, 2007, 13.
Chen Daijie, Guo Beining, Yang Xinyi, et al. Drug resistance
mechanism of Acinetobacter baumannii[J]. Chinese Journal of
infection and chemotherapy, 2015 (3).
Roberts J A, Lipman J. Pharmacokinetic issues for antibiotics
in the critically ill patient.[J]. Critical Care Medicine, 2009,
(3):840.
Professional Committee of infectious diseases of China Medical
Education Association. Expert consensus on clinical application
of antimicrobial pharmacokinetic / pharmacodynamic theory[J].
Chinese Journal of tuberculosis and respiration, 2018,41 (6):
-446.
Chen Jing Jing, Qian Peipei, Cao Kai, et al. Comparison and
analysis of adverse drug reaction correlation evaluation method
and Noel’s evaluation scale method in China[J]. China Pharmaceutical
, Vol. 34, No. 8, pp. 988-992, istic Ca, 2020.
Joel g. Hardman, Lee E. limbird, Jin Youyu. Pharmacological
basis of Goodman Gilman therapeutics[J]. People’s Health Publishing
House, 2004.
Cui Hongxia, Yu Suwen. Retrospective analysis of 125 cases of
adverse reactions of tegacyclin[J]. China pharmacovigilance,
, v.15; No.140(08):45-48.
Yu Wen, Sui Jie, Li Chengjian. Literature review of adverse reactions
of tegacyclin[J]. Chinese Journal of drug abuse prevention
and control, 2018, 024 (001): 45-46.
DOI: https://doi.org/10.12346/jnp.v1i1.4253
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Han Fang, Zhe Wang
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.